BCL2 and cancer: It is intriguing that the apoptosis inhibitor BCL2 is among the target genes of YAP1, a fact that could contribute to YAP1 dependency in 20q11.21 amplified cancers, given that the related BCL2L1 protein is dysregulated in these cancers [29].